Enhanced Fluorescence Detection System

A novel system for improved fluorescence detection, comprising optimized fluorescent labels, quenching-reducing agents, and enhanced imaging methods to increase signal intensity and accuracy in various applications.

The original patent disclosed methods for enhancing fluorescence signals and reducing quenching. However, these methods have limitations in terms of dye-to-protein ratios, spacer molecule conjugation, and imaging applications. The new inventive concept addresses these limitations by introducing optimized fluorescent labels, quenching-reducing agents, and enhanced imaging methods to improve the accuracy and sensitivity of fluorescence detection.

The enhanced fluorescence detection system comprises a fluorescently labeled biomolecule having an optimized dye-to-protein ratio to reduce quenching. The system also includes a fluorescence enhancer compound that increases the fluorescent signal of the biomolecule. Additionally, the system utilizes modified spacer molecules, such as sulfo-NHS-acetate or MS-(PEG)4, to reduce quenching. The imaging method involves labeling biomolecules with fluorescent dyes having optimized spacer molecules and using the labeled biomolecules in various imaging applications, including immunofluorescence and cellular imaging. The system also includes a quenching-reducing agent that increases the fluorescent signal of the biomolecule, thereby improving the accuracy and sensitivity of fluorescence detection.

The new inventive concept introduces novel combinations of optimized fluorescent labels, quenching-reducing agents, and enhanced imaging methods that provide improved fluorescence detection. The inventive concept's novelty lies in the optimized dye-to-protein ratios, modified spacer molecules, and quenching-reducing agents, which are not present in the original patent. The inventive step is the combination of these elements to provide a system that improves the accuracy and sensitivity of fluorescence detection.

Alternative embodiments of the inventive concept include using different types of fluorescent dyes, modifying the spacer molecules with various functional groups, and incorporating additional quenching-reducing agents. Variations of the imaging method include using different imaging modalities, such as confocal microscopy or super-resolution microscopy, and applying the system to various biological samples, including tissues and cells.

The enhanced fluorescence detection system has significant commercial potential in various industries, including biomedical research, diagnostics, and pharmaceuticals. The system can be used in various applications, including cancer diagnosis, biomarker detection, and drug development. The market for fluorescence detection systems is growing rapidly, and the new inventive concept is poised to capture a significant share of this market.